The Valley Desk

NCT07611214 · Interventional trial

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

Overall registry status Recruiting

Phase 4

Conditions Lupus Nephritis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov